Skip to Content

M 2 L N (Lamivudine 150 mg)

Pill with imprint M 2 L N is White, Capsule-shape and has been identified as Lamivudine 150 mg. It is supplied by Mylan Pharmaceuticals Inc..

Lamivudine is used in the treatment of hepatitis b; nonoccupational exposure; occupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 2 L N

Lamivudine 150 mg M 2 L N

Lamivudine

Imprint
M 2 L N
Strength
150 mg
Color
White
Size
13.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (nrtis)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-5169
Inactive Ingredients
hypromelloses, magnesium stearate, microcrystalline cellulose, propylene glycol, sodium starch glycolate type A potato, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "M 2 L N"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.